These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 13938596)

  • 21. [Studies with a derivative of the pyrimido-pyrimidines, "RA 8"].
    BURGOS DE PABLO A
    Rev Esp Cardiol; 1961 Oct; 14():758-805. PubMed ID: 13874849
    [No Abstract]   [Full Text] [Related]  

  • 22. [Function and energy metabolism of the exhausted heart muscle under the effects of 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)-pyrimidine].
    SIESS M
    Arzneimittelforschung; 1962 Jul; 12():683-91. PubMed ID: 13912692
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of coronary insufficiency with Persantin].
    RIEGLER E
    Wien Z Inn Med; 1961 Mar; 42():140-2. PubMed ID: 13741533
    [No Abstract]   [Full Text] [Related]  

  • 24. [Action of 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimido(5,4-d)pyrimidine on the dynamics of the isolated, spontaneously beating heart of warm-blooded animals].
    GEBHARDT W
    Arzneimittelforschung; 1961 Oct; 11():957-62. PubMed ID: 13897429
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the therapy of coronary insufficiency].
    DUETSCH L
    Ther Ggw; 1960 May; 99():228-34. PubMed ID: 13818454
    [No Abstract]   [Full Text] [Related]  

  • 26. [A contribution to the therapy of coronary insufficiency].
    LEIMGARDT H
    Medizinische; 1959 Dec; No 49():2408-12. PubMed ID: 14415455
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental evaluation of drugs for coronary insufficiency induced by hypoxemia and picrotoxin.
    VARMA DR; MELVILLE KI
    Am J Cardiol; 1962 Mar; 9():471-81. PubMed ID: 13924902
    [No Abstract]   [Full Text] [Related]  

  • 28. [The treatment of coronary insufficiency with 2'-(2-diethylaminoethoxy)-3-phenylpropiophenone hydrochloride].
    TRIGGIANI G; LATORRE F; BASSI R
    Minerva Med; 1960 Sep; 51(70 Suppl):2852-7. PubMed ID: 13778065
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical study on flavone-7-hydroxyethylacetate in coronary insufficiency.
    SCHWARTZ A; MARKMAN A; PORTUGAL OP; PFEFERMAN A
    Arq Bras Cardiol; 1959 Sep; 12():205-14. PubMed ID: 14443956
    [No Abstract]   [Full Text] [Related]  

  • 30. Nitroglycerin and isosorbide dinitrate in coronary insufficiency.
    LESLIE RE
    Tex State J Med; 1961 Jun; 57():432-4. PubMed ID: 13761164
    [No Abstract]   [Full Text] [Related]  

  • 31. [STUDY OF THE PROTECTIVE EFFECT OF A PYRIMIDO-PYRIMIDINE DERIVATIVE (PERSANTIN) ON EXPERIMENTAL ANOXIA OF THE MYOCARDIUM IN THE RAT].
    DUBOISTESSELIN R
    Therapie; 1964; 19():1291-6. PubMed ID: 14227792
    [No Abstract]   [Full Text] [Related]  

  • 32. [CLINICAL STUDY OF THE EFFECT OF ISOPTIN AND ISOPTIN S IN PATIENTS WITH CORONARY INSUFFICIENCY].
    TSCHIRDEWAHN B; KLEPZIG H
    Dtsch Med Wochenschr; 1963 Aug; 88():1702-7. PubMed ID: 14045376
    [No Abstract]   [Full Text] [Related]  

  • 33. [Preliminary observations on the treatment of coronary insufficiency with 2'-(2-diethylaminoethoxy)-3-phenylpropiophenone hydrochloride (LG--11457)].
    CHELLA S
    Minerva Med; 1960 Sep; 51(70 Suppl):2847-52. PubMed ID: 13692742
    [No Abstract]   [Full Text] [Related]  

  • 34. [TREATMENT OF CORONARY INSUFFICIENCY WITH N,N'-DIMETHYL-N,N'-BIS-(3-(3',4',5'-TRIMETHOXYBENZOXY)-PROPYL)-ETHLENEDIAMINE-DIHYDROCHLORIDE (ST 7090, USTIMON)].
    LANG O
    Wien Klin Wochenschr; 1965 Apr; 77():305-7. PubMed ID: 14311489
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical experimentation with a new substance (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine in syndromes caused by coronary insufficiency].
    DE FELICE D; ROSSETTO L
    Gazz Int Med Chir; 1962 Sep; 66():1976-84. PubMed ID: 14025758
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical observations on the use of a new synthetic agent (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine, Segontin) in coronary insufficiency syndromes].
    CESARI L
    Gazz Int Med Chir; 1962 Sep; 66():1994-2004. PubMed ID: 14019763
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of 2,6-bis(diethanolamino)-4-piperidino-pyrimido(5,4-D)pyrimidine (RA233) on the coronary circulation of the acutely transplanted dog heart: comparison with dipyridamole and adenosine.
    Paoloni HJ; Wilcken DE
    J Pharmacol Exp Ther; 1972 Oct; 183(1):137-45. PubMed ID: 4562619
    [No Abstract]   [Full Text] [Related]  

  • 38. Medical management of coronary artery disease. A resume of its pharmacology.
    CALESNICK B
    Angiology; 1963 Jan; 14():17-22. PubMed ID: 14017870
    [No Abstract]   [Full Text] [Related]  

  • 39. [ON THE THERAPY OF CORONARY INSUFFICIENCY].
    BUEDINGEN F; MOELLER HC
    Ther Ggw; 1964 Apr; 103():436-54. PubMed ID: 14198155
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of coronary insufficiency with high doses of pyrimido-pyrimidine].
    D'Anelli A
    Minerva Cardioangiol; 1970 Feb; 18(2):141-6. PubMed ID: 5446673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.